The impact of interbody fusion devices' surface nanotechnology on bone growth and fusion — Drs. Barbara Boyan & Paul Slosar weigh in

Written by Megan Wood | September 14, 2016 | Print  |

How does surface nanotechnology of interbody fusion devices impact bone growth and fusion?

Barbara Boyan, PhD, dean of Richmond-based Virginia Commonwealth University's School of Engineering, will answer this question during a Titan Spine-sponsored webinar. The biomaterial science expert will explain how biochemical processes spur early-stage bone growth as well as dive into the affect of material and topographies at the micro and nano levels on osteoblastic differentiation of attachment-dependent cells.

 

Also tune in to hear Paul Slosar, MD, president of San Francisco-based SpineCare Medical Group, expand on clinical outcomes achieved with these nano-enhanced implants.

 

To register for the webinar on Sept. 28 from 12-1 p.m., click here.

 

More articles on devices:
GE Healthcare receives FDA clearance for MAGiC MR technique: 5 things to know
NuVasive names Jason Hannon president, COO & Patrick S. Miles vice chairman: 5 key notes
33% of orthopedic surgeons to use robotic systems by 2018: 6 things to know

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months